Finally, mice bearing xenografts derived from MES GSCs treated with joint UCHL3 depletion and IR displayed a lower rate of tumor formation and prolonged survival compared to those following IR treatment, and POLD4 overexpression inhibited this synergism (Fig. 6I, J, K). The gene discussed is UCHL3; the disease is neoplasm.